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ARTICLE
Model- Based Prediction of Plasma Concentration and 
Enterohepatic Circulation of Total Bile Acids in Humans
Benjamin Guiastrennec1, David P. Sonne2,3, Martin Bergstrand1,6, Tina Vilsbøll3,4, Filip K. Knop3,4,5 and Mats O. Karlsson1,*
Bile acids released postprandially can modify the rate and extent of lipophilic compounds’ absorption. This study aimed to 
predict the enterohepatic circulation (EHC) of total bile acids (TBAs) in response to caloric intake from their spillover in 
plasma. A model for TBA EHC was combined with a previously developed gastric emptying (GE) model. Longitudinal gallblad-
der volumes and TBA plasma concentration data from 30 subjects studied after ingestion of four different test drinks were 
supplemented with literature data. Postprandial gallbladder refilling periods were implemented to improve model predic-
tions. The TBA hepatic extraction was reduced with the high- fat drink. Basal and nutrient- induced gallbladder emptying 
rates were altered by type 2 diabetes (T2D). The model was predictive of the central trend and the variability of gallbladder 
volume and TBA plasma concentration for all test drinks. Integration of this model within physiological pharmacokinetic 
modeling frameworks could improve the predictions for lipophilic compounds’ absorption considerably.
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WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
✔   Due to their solubilizing action, bile acids are essential 
for the intestinal absorption of lipophilic drug compounds. 
However, the difficulty of direct intestinal sampling com-
bined with the high variability in bile secretion and recircu-
lation processes makes the determination of the local 
intestinal bile acid concentrations challenging.
WHAT QUESTION DID THIS STUDY ADDRESS?
✔   Can the postprandial spillover of bile acids in plasma 
be linked to the EHC of bile acids, and what are the impor-
tant factors to consider?
WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
✔   The proposed modeling framework describes the 
complex relationship among the GE, the gallbladder 
 emptying–refilling patterns, and the EHC of bile acids in 
response to the intake of test drinks.
HOW MIGHT THIS CHANGE DRUG DISCOVERY, 
DEVELOPMENT, AND/OR THERAPEUTICS?
✔   This modeling framework could be used during the de-
velopment of orally administered compounds by linking 
the absorption variability to postprandial changes in 
plasma bile acid concentrations. The model predictions 
may also be used to support research on pathologies af-
fecting the EHC of bile acids.
Study Highlights
Bile acids are essential for the absorption of lipophilic mol-
ecules through their solubilizing action. They are water sol-
uble, amphipathic molecules formed in the liver as an end 
product of cholesterol metabolism. The total bile acids’ 
(TBAs) pool consists of primary and secondary bile acids 
found as glycine- conjugated, taurine- conjugated, and un-
conjugated forms.1,2 Bacteria in the terminal part of the 
small intestine are responsible for the deconjugation of 
conjugated bile acids and the synthesis of secondary bile 
acids.2
During the inter- digestive phase, most bile acids are 
stored and concentrated in the gallbladder. Approximately 
10% of the bile coming from the liver can flow into the du-
odenum during this period.3 In the postprandial state, the 
entry of macronutrients (i.e., fats, proteins, and carbohy-
drates) in the duodenum triggers gallbladder contractions 
and opening of the Oddi sphincter, resulting in the flow 
of bile to the duodenum.2–4 About 30% of the bile acids 
(mostly unconjugated bile acids) are absorbed in the upper 
small intestine by passive diffusion.5,6 Due to ionization, the 
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remaining 70% are unable to cross the cell membranes and 
are propelled intraluminally down the small intestine. Along 
the small intestine, the bile acid concentration increases as 
water is progressively being absorbed. When the intestinal 
bile acid concentration reaches the critical micellar concen-
tration, micelles start to form and emulsify lipophilic mol-
ecules.1,7 In the terminal ileum, about 95% of bile acids 
are reabsorbed by active transport and transferred to the 
liver via the portal vein, the remaining 5% is excreted in 
the feces.1 In the liver, bile acids are efficiently conjugated 
and extracted (55–90%). A fraction escapes the hepatic ex-
traction and reaches the systemic circulation: this process 
constitutes the spillover of bile acids from the portal vein 
into the systemic circulation.2,8 The distribution of bile acids 
to the peripheral tissues is limited due to their high affinity for 
serum proteins (>42%) and to the efficiency of the hepatic 
extraction.2,9 The extracted bile acids are actively secreted 
into the biliary canaliculus, from which they either flow back 
to the gallbladder or directly to the small intestine.2,3 This 
efficient recycling is known as the enterohepatic circulation 
(EHC) of bile acids and can occur several times throughout 
the postprandial period.2
Lipophilic drug compounds suffer from low bioavailability 
if administered in fasting condition. However, the concomi-
tant administration of food can increase their bioavailability 
thanks to the solubilizing action of bile acids.10,11 Given the 
complexity of the EHC of TBA and the influence of external 
factors (e.g., meal properties), the time- course of bile acids’ 
intestinal concentrations is subject to substantial variability 
between and within individuals.10,12,13 The identification and 
quantification of factors causing this variability is challenged 
by the complex and disruptive procedures required to di-
rectly measure TBA concentrations in different phases of the 
EHC.8,14,15 Thus, accurate in vivo predictions of the rate and 
extent of lipophilic compounds’ absorption is complex.13,16
Nonlinear mixed effect (NLME) models have demonstrated 
their utility in the development of complex dynamic sys-
tems.17,18 Mechanism- based NLME models can be used to 
simultaneously predict the concentration time- course in mul-
tiple compartments while investigating the sources of vari-
ability.18 An NLME approach was used to develop a modeling 
framework predicting the EHC of TBA in response to various 
caloric intakes. The objectives were set (i) to establish the 
relationship between postprandial gallbladder emptying and 
the kinetics of nutrients in the upper small intestine and (ii) to 
link gallbladder emptying to the spillover of TBA in plasma.
MATERIALS AND METHODS
Study design
Data were obtained from a previously published clinical 
study in 15 patients with type 2 diabetes (T2D) and 15 
healthy control subjects matched based on gender, age, 
and body mass index.19,20 Details of the population demo-
graphics are provided in Table S1. The study was approved 
by the scientific- ethical committee of the Capital Region of 
Denmark and conducted according to the principles of the 
Helsinki Declaration II.
In a crossover design, all subjects were successively ad-
ministered four test drinks after an overnight (10- hour) fast. 
Test drinks consisted of a 75- g oral glucose tolerance test 
(OGTT) and three isocaloric, isovolemic solutions with low, 
medium, and high fat content (Table 1). The plasma concen-
trations of the 12 most common bile acids (i.e., the glycine- 
conjugated, taurine- conjugated and unconjugated forms 
of the following bile acids: cholic acid (CA), chenodeoxy-
cholic acid, deoxycholic acid, and ursodeoxycholic acid), 
were repeatedly measured from 20 minutes prior and up to 
240 minutes after test drink administration (Figure 1). TBA 
concentrations were determined by calculating the molar 
sum of the 12 measured bile acids. Gallbladder volumes 
were measured from 10 minutes prior and up to 60 min-
utes after test drink administration (Figure 1). Gallbladder 
volumes were determined by ultrasonography, as described 
elsewhere.20 The detailed composition and conjugation of 
TBA plasma concentration is provided in Figure 2 for healthy 
individuals and in Figure S1 for patients with T2D.
Parameter estimation and model selection
The NLME models were developed using the first- order 
conditional parameter estimation method with inter-
action in NONMEM version 7.3.0 (Icon Development 
Solutions, Ellicott City, MD) and aided by PsN version 4.7.9 
(Department of Pharmaceutical Biosciences, Uppsala 
University, Uppsala, Sweden).21 Model selection was 
based on changes in the objective function value using a 
significance level of P < 0.05, physiological plausibility, pa-
rameter uncertainty, and graphical diagnostics. Parameter 
uncertainty was obtained from the NONMEM sandwich es-
timator computed following an importance- sampling step. 
Visual predictive checks, comparing percentiles of the ob-
servations with the confidence intervals (CIs) of the corre-
sponding percentiles from 1,000 simulations, were used for 
evaluation of the models’ predictive performances.22
Model development
Gastric emptying model integration
A previously published gastric emptying (GE) model was 
used to predict the kinetics of ingested nutrients in the 
upper small intestine. The latter was subsequently used to 
predict gallbladder emptying in response to different test 
drinks.20,23 The GE model was developed based on data 
from the same clinical trial as the present study meaning 
that individual GE parameter estimates (i.e., empirical Bayes 
estimates) were available. In this model, the ingested nutri-
ents remain in the stomach until the onset of GE. The GE 
rate is controlled by a feedback loop of the caloric content 
in the upper small intestine. The model was implemented 
via an individual pharmacokinetic parameter with standard 
Table 1 Properties of the test drinks
Test drink OGTT 75 g Low fat Medium fat High fat
Volume (ml) 300 350 350 350
Carbohydrate (g) 75 107 93 32
Protein (g) 0 13 11 3
Fat (g) 0 2.5 10 40
Energy (kcal)a 300 503 506 500
OGTT, oral glucose tolerance test.
aCaloric content calculated using 4 kcal/g for carbohydrates and proteins 
and 9 kcal/g for fats.41
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errors approach, allowing for proper handling of the uncer-
tainty in the individual GE parameters estimates.24
Total bile acids distribution model
Due to the continuous recirculation of TBA, the determination 
of their plasma distribution was not possible solely based on 
the clinical data. Instead, published longitudinal data on ra-
diolabeled total CA administered intravenously were used as 
surrogate for TBA distribution; the distribution of total CA and 
TBA were herein assumed to be similar.25 One- compartment 
and two- compartment candidate models were compared. In 
both cases, the total CA elimination was mediated through a 
liver compartment for which the volume was calculated using 
the Small et al.26 equation (fasting hepatic blood flow set to 
1.5 l/min).
Enterohepatic circulation modeling framework 
development
The general structure of the EHC modeling framework of 
TBA was designed around the key physiological compo-
nents characterizing the EHC. Gallbladder volume and TBA 
data were herein modeled simultaneously. Gallbladder 
emptying was driven by a stimulatory function of the 
amount of fat equivalents in duodenum (efatduod). Linear 
and Michaelis- Menten type functions were investigated. 
The efatduod was generated by converting the amount of 
carbohydrates and proteins in duodenum into a fat equiva-
lent by estimating their relative potency (Eq. 1).
where gcarb,duod, gfat,duod, and gprot,duod represent the amount 
in grams of carbohydrates, fats, and proteins in the duode-
num predicted by the GE model. The Pcarb and Pprot represent 
the relative potency of carbohydrates and proteins in relation 
to fat (e.g., Pcarb of 10% would indicate that 10 g of carbo-
hydrates give the same effect on gallbladder as 1 g of fat). 
Graphical exploration of observed postprandial TBA plasma 
concentrations revealed the occurrence of two peaks com-
monly occurring around 30 and 120 minutes (Figure 1, lower 
panels), which were assumed to be associated with TBA 
recirculation.8 The assumption of a temporary postprandial 
gallbladder refilling (GBrefill) period (Eq. 2) was tested on the 
rate of gallbladder emptying (RGB,out) in order to predict dou-
ble peaks despite a sustained emptying signal of efatduod.
15
(1)efatduod= (gcarb,duod ⋅Pcarb)+ (gprot,duod ⋅Pprot)+gfat,duod
(2)
GBrefill (t)=1−
1
1+e−Sloperefill ⋅(t−Trefill onset )
+
1
1+e−Sloperefill ⋅(t−Trefill onset−Trefill duration)
Figure 1 Postprandial mean gallbladder volumes (top) and total plasma bile acid concentrations (bottom) in response to the intake 
(vertical line) of a 75- g oral glucose tolerance test (OGTT) and three isocaloric (500 kcal), isovolemic (350 ml) test drinks with low (2.5 g 
fat, 107 g carbohydrate, 13 g protein), medium (10 g fat, 93 g carbohydrate, 11 g protein), and high (40 g fat, 32 g carbohydrate, 3 g 
protein) fat content (colors) in 15 healthy subjects (left) and 15 patients with type 2 diabetes (right). Error bars represent the standard 
error of the mean.
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where t represents the time since test drink intake, and 
Sloperefill the onset and offset steepness of gallbladder re-
filling. The Trefill_onset represents the time to 50% of the max-
imal gallbladder refilling onset and Trefill_duration the duration 
for which gallbladder refilling was at more than half of its 
maximal effect. The RGB,out was converted from a volume 
per unit of time to an amount of TBA entering the upper 
small intestine compartment per unit of time by assuming 
a mean TBA concentration of 113 mM in the gallbladder.15 
The parameter FAU determined the TBA fraction absorbed in 
the upper small intestine. Delays throughout the TBA small 
intestine transit were investigated by successively splitting 
the upper and lower small intestine into one, two, or three 
subcompartments. The size of the TBA pool was assumed 
to be constant (i.e., the model predicted no TBA loss to the 
colon or de novo TBA production by the liver). This was jus-
tified as these two processes would under physiological 
condition cancel out each other.
The liver compartment was implemented using a well- 
stirred type model, for which the volume was calculated 
using the Small et al. equation.26,27 The fasting hepatic 
blood flow was set to 1.5 l/min and increased by 35% upon 
test drink intake.28 The hepatic extraction (EH) determined 
the TBA fraction arriving to the liver returned to the gall-
bladder. Constant and concentration- dependent Michelis- 
Menten EH functions were evaluated. The fraction escaping 
EH (FH = 1 − EH) was directed to the plasma compartment. 
The previously described TBA distribution model was inte-
grated into the EHC model framework, without re- estimating 
the distribution parameters.
Sensitivity analysis
The sensitivity of the selected model to fixed parameter 
(i.e., literature) values was evaluated through (i) simulations 
and (ii) re- estimation. In step one, alternative versions of 
the selected model were created by modulating the value 
of each fixed parameter by ±25%. For each model, 1,000 
simulated datasets were created and summarized into 
the 95% CI around the population median for the simu-
lated gallbladder volume and TBA plasma concentrations. 
Simulations from the alternative models were then graph-
ically compared to simulations from the reference model. 
In step two, the alternative models for which meaning-
ful differences could be observed in step one were re- 
estimated. The predictions of each re- estimated model 
were again compared to the reference model (see step 
one) in order to ensure for the unidentifiability of the fixed 
parameters.
Covariate analysis
Weight- based allometric scaling was applied to vol-
umes and clearance parameters using exponents of 
1 and 3/4, respectively, and a reference body weight of 
70 kg.29 Effects of age, gender, T2D, test drink fat, and 
Figure 2 Composition (top) and conjugation (bottom) of the mean plasma concentration of total bile acids vs. time for each of the four 
test drinks in healthy subjects. The vertical lines represent the time of the test drink intake. CA, cholic acid; CDCA, chenodeoxycholic 
acid; DCA, deoxycholic acid; OGTT, oral glucose tolerance test; UDCA, ursodeoxycholic acid.
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carbohydrate contents were investigated on key EHC 
model parameters. Covariate selection was performed 
through a stepwise covariate modeling approach with for-
ward inclusion (P < 0.05) and backward deletion (P ≥ 0.01) 
steps. Continuous covariates were implemented linearly 
as fractional change in the typical parameter value for 
each unit change in the covariate to its median value. 
Categorical covariates were implemented as fractional 
change in the typical parameter value in relation to the 
most common category.
Stochastic models
Due to long runtimes, a single variability term accounting 
for both between- subject variability (BSV) and between- 
occasion variability (BOV) was estimated for each pa-
rameter. The relative contribution of BSV and BOV were 
computed from the empirical Bayes estimates of the total 
variability. For parameters bound between 0 and 1, a logit 
transformation was applied prior to the variability imple-
mentation.30 Log- normal distributions were used for pa-
rameters in the normal domain and normal distributions for 
parameters in the logit domain. Correlations between pa-
rameters at the individual level were evaluated. Occasions 
were defined by the intake of one of the four test drinks. 
Proportional, additive, and combined models were tested 
for the residual unexplained variability.
RESULTS
A schematic representation of the TBA EHC modeling 
framework is provided in Figure 3. Parameter estimates 
are reported in Table 2 and the model code in Figure S2. 
Contributions of BSV and BOV to the estimated total variabil-
ity in each parameter are provided for reference in Table S2.
Total bile acids distribution model
The two- compartment distribution model was re-
tained (P < 0.001) and appropriately described the data 
(Figure S3). The estimated typical volume of central 
(VC = 2.84 l) and peripheral (VP = 4.07 l) compartments, and 
the intercompartmental clearance (QD = 0.173 l/min) for a 
70- kg individual indicated a rapid and contained distribution.
Enterohepatic circulation modeling framework 
development
A total of 920 gallbladder measurements and 1,236 TBA 
plasma concentration samples were gathered from 30 sub-
jects. One patient exhibited unphysiological TBA concen-
trations at 15 minutes (~27 times higher than baseline), thus, 
this sample was excluded from the analysis.
The rate of gallbladder emptying, RGB,out, was best de-
scribed by a linear function of efatduod on the basal (i.e., fast-
ing) gallbladder emptying rate constant (KRB; Eq. 3).
Figure 3 Schematic representation of the developed model. Test drinks were administered into the stomach. The gastric emptying rate 
constant (KG) was inhibited by calories in the upper small intestine. KUL was the rate constant of calories disappearance from the upper 
small intestine (SI), and KDJ from the duodenum. Nutrients (i.e., fats, proteins, and carbohydrates) and calories were also nonlinearly 
absorbed, RAMAX describing the maximal rate and KM the potency of their absorption. The gallbladder release rate constant (KRB) was 
stimulated by a signal of the fat equivalent amount in the duodenum (efatduod). The gallbladder had refilling periods starting at the onset 
(Trefill_onset) and for a duration determined by Trefill_duration. The steepness of the onset and offset were determined by the refilling slope 
(Sloperefill). Once released from the gallbladder, total bile acids (TBAs) were either absorbed in the upper small intestine at the rate KA,U 
or transited toward the lower small intestine at the rate KTUL. KA,L mediated the lower small intestine transit and the absorption rate 
constant of bile acids. Upon arrival to the liver, the TBAs were extracted back to the gallbladder against the concentration gradient 
(CH/CGB). The fraction escaping the hepatic extraction (FH) spilled to the plasmatic and peripheral compartments. The QH and QD, 
respectively, represented the hepatic blood flow and the distribution clearance. The rate constant of transit from the lower small 
intestine to the colon (KTLC) and the liver TBA production rate (RTBA) were assumed to compensate each other in the model and were 
herein represented for illustration purpose only. Magnifying glasses indicate variables that were simultaneously modeled: gallbladder 
volume and TBA plasma concentrations.
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where GBvol is the gallbladder volume at a given time, and 
Slopeefat is the slope of the effect of efatduod on KRB. The 
total variability linked to gallbladder emptying parameters 
was substantial, with a 95% coefficient of variation (CV) for 
the half- life of gallbladder emptying (HLRB = 0.693/KRB) and 
100% CV for Slopeefat. Throughout the covariate search, 
HLRB was found to be decreased in subjects with T2D 
(P < 0.001; Eq. 4).
where TVHLRB is the typical value of HLRB, T2D is a variable 
set to 0 for healthy volunteers, and 1 for subjects with T2D 
and ηi1 the total variability on HLRB. The parameter Slopeefat 
was found to be negatively correlated with individual’s age 
(AGE, P < 0.001) and T2D status (P = 0.104; Eq. 5).
where TVSlopeefat is the typical value of Slopeefat, and ηi1 the 
total variability on Slopeefat. Implementation of the gallbladder 
refilling function (Eq. 2) significantly improved the prediction of 
the double peaks observed in the TBA plasma concentration 
data (Figure 1, lower panels). The Trefill_onset and Trefill_duration 
 parameters were estimated to 25.6 minutes (70% CV) post-
dose and 156 minutes (35% CV), respectively, indicating an 
early and prolonged effect throughout the postprandial state. 
The typical value of Sloperefill was small (0.155), indicating a pro-
gressive transition throughout the onset and offset of refilling.
The FAU was found to increase from 21.6% for fat- 
containing drinks to 48.6% for OGTT 75 g. Splitting the 
upper small intestine into subcompartments did not improve 
model predictions. However, significant improvements were 
seen when the lower small intestine was split into three sub-
compartments and absorption restricted to the terminal part. 
The mean TBA transit time throughout the lower small intes-
tine (MTTA,L) was estimated to 109 minutes (47% CV). The 
MTTA,L was shorter in female subjects (−27.9%; P < 0.001) 
and positively correlated with the amount of ingested carbo-
hydrates (+0.614%/g; P < 0.001) as illustrated in Eq. 6.
(3)RGB,out=GBvol ⋅KRB ⋅ (1+Slopeefat ⋅efatduod) ⋅GBrefil
(4)HLRB=TVHLRB ⋅ (1−0.481 ⋅T2D) ⋅exp (ηi1)
(5)
Slopeefat=TVSlopeefat⋅(1−0.025 ⋅ (AGE−64))
⋅(1−0.329 ⋅T2D) ⋅exp (ηi2)
Table 2 Parameter estimates and uncertainty for the selected models
Gallbladder emptying model Enterohepatic circulation model
Parameters (unit) Estimates (CI95) BSV
a CV% (CI95) Parameters (unit) Estimates (CI95) BSV
a CV% (CI95)
Base GB (ml)b 29.4 (25.3 to 33.4) 27 (22 to 31) HLTUL (minutes) 59.7 (42 to 77.3)
HLRB (minutes) 1,250 (897 to 1,610) 95 (78 to 110) FAU (%) 21.6 (15.8 to 27.3) 0.62 (0.43 to 0.77)
c
T2D–HLRB (%) −48.1 (−69.1 to −27.2) OGTT–FAU (%) +125 (93.8 to 157)
Slopeefat 101 (69.6 to 133) 100 (76 to 120) MTTA,L (minutes) 109 (85.5 to 133) 47 (27 to 61)
Age–Slopeefat  
(%/year)
−2.50 (−4.00 to −1.00) Carbs–MTTA,L (%/g) +0.614 (0.305 to 0.924)
T2D–Slopeefat (%) −32.9 (−55.7 to −10.1) Female–MTTA,L (%) −27.9 (−62.6 to +6.87)
RAMAX (kcal/minutes) 2.29 fixed EH (%) 63.8 (54.1 to 73.6) 0.59 (0.3 to 0.78) 
c
KM (kcal) 25.1 fixed High fat–EH (%) −29.4 (−109 to +50.1)
HLDJ (minutes) 2.52 (1.78 to 3.27) QH (l/minutes) 
b 1.5 fixed (fasting) 
2.0 fixed (fed)
Pfat (%) 100 fixed VC (l) 
b 2.84 fixed
Pcarb (%) 5.74 (3.99 to 7.48) VP (l) 
b 4.07 fixed
Pprot (%) 82.3 (32.7 to 132) QD (l/minutes) 
b 0.173 fixed
Sloperefill 0.155 (0.055 to 0.255) TBA conc. GB (mM) 113 fixed
Trefill_onset (minutes) 25.6 (20.3 to 30.9) 70 (28 to 95)
Trefill_duration (minutes) 156 (130 to 182) 35 (15 to 47)
Add. err. (ml) 4.27 (1.85 to 6.7) Prop. err. (%) 31.8 (25.9 to 36.8)
Prop. err. (%) 10.2 (7.54 to 12.3)
Add. Err., additive part of the residual unexplained variability; AGE- slopeefat, effect of age on slopeefat; Base GB, baseline gallbladder volume; BSV, between- 
subject variability; Carbs- MTTA,L, effect of the amount of ingested carbohydrates on MTTA,L; CI95, 95% confidence interval; CV, coefficient of variation; EH, 
hepatic extraction; FAU, fraction of total bile acids absorbed in the upper small intestine; Female- MTTA,L, relative difference in MTTA,L with female subjects in 
comparison to males; High fat- EH, relative difference in EH with the high- fat test drink in comparison to the other test drinks; HLDJ, half- life of the nutrient 
transfer rate between duodenum and jejunum; HLRB, half- life of the basal (i.e., fasting) gallbladder emptying rate; HLTUL, half- life of total bile acids transfers 
from upper to lower small intestine; KM, potency of the caloric absorption; MTTA,L, mean transit time of total bile acids throughout the lower small intestine; 
OGTT- FAU, relative change in FAU with the oral glucose tolerance test 75 g test drink; Pcarb, Pfat, Pprot, potency on gallbladder emptying per gram of carbohy-
drates, fats, and proteins in relation to 1 g of fat; Prop. err., proportional part of the residual unexplained variability; QD, total bile acids intercompartmental 
clearance; QH, hepatic blood flow; RAMAX, maximal nutrients absorption rate; Slopeefat, slope of the effect of the amount of fat equivalent on gallbladder 
emptying; Sloperefill, steepness of the onset and offset of gallbladder refilling; T2D–HLRB, effect of type 2 diabetes on HLRB; T2D–Slopeefat, effect of type 2 
diabetes on Slopeefat; TBA conc. GB, fasting total bile acid concentration in the gallbladder; Trefill_duration, duration for which the gallbladder refilling is at more 
than half of its maximal effect; Trefill_onset, time to 50% of maximal gallbladder refilling onset; VC, VP, total bile acids central and peripheral volumes of 
distribution.
aIn the present case BSV represents the sum of the between- subject variability and between- occasion variability. The contribution of each of these two 
components is provided in Table S2. The off- diagonal elements are reported in Table S3.
bParameter allometrically scaled in reference to a 70- kg individual and using an allometric exponent of 1 for volumes and 3/4 for clearances.
cStandard deviation for additive variability on the logit scale.
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where TVMTTA,L is the typical value of MTTA,L, FEM a vari-
able set to 1 for female subjects and 0 for male subjects, 
gcarb the total amount of carbohydrates ingested, and ηi3 the 
unexplained variability on MTTA,L. An EH of 63.8%, constant 
over time, best fitted the TBA plasma concentration data. 
The high fat test drink was, however, associated with a lower 
EH, estimated to 45.0%.
Estimating the covariance between individual model 
parameters (gallbladder baseline volume, HLRB, Slopeefat, 
Trefill_onset, Trefill_duration, FAU, MTTA,L, and EH) greatly improved 
the fit of the model. The full variance- covariance matrix (i.e., 
NONMEM $OMEGA BLOCK) is reported in Table S3. The 
residual unexplained variability was best described by a 
combined model for gallbladder volume and a proportional 
model for TBA plasma concentrations. Overall, the selected 
models displayed good predictive performances across the 
range of test drinks (Figure 4). Simulation- based model pre-
dictions of gallbladder volume and TBA plasma concentra-
tions are illustrated in Figure 5.
Sensitivity analysis
A local sensitivity analysis was carried out on all fixed pa-
rameters, namely: TBA concentration in the gallbladder, QH, 
QD, VC, and VP parameters. The model simulations revealed 
that a change in QD, VC, or VP only had minor effect on gall-
bladder volume and TBA plasma concentration predictions. 
However, ±25% change in TBA concentration in the gall-
bladder or QH resulted in meaningful differences in the sim-
ulated medians in comparison to the reference model. After 
a re- estimation step, the model predictions medians were, 
however, similar to the reference model.
DISCUSSION
The proposed EHC modeling framework was predictive of 
the central trend and the variability in gallbladder empty-
ing and TBA plasma concentration longitudinal data in re-
sponse to test drink intakes. The use of an NLME approach 
allowed the simultaneous integration of clinical data, a 
previously developed GE model,23 published radiolabeled 
bile acids data25, and of published physiological parameter 
values.15,26,28 Our main findings suggest that the multiple 
peaks observed in the TBA plasma concentration data can 
be explained by postprandial gallbladder refilling periods 
and the presence of a high fat effect due to reduced hepatic 
extraction.
The postprandial emptying of the gallbladder is primarily 
attributed to the increase in plasma cholecystokinin con-
centrations, a gut hormone released when food comes in 
contact with cells of the upper small intestine.4,31 Our pre-
vious work has, however, shown that postprandial plasma 
cholecystokinin concentrations were not a good predictor 
of gallbladder emptying. Instead, using efatduod, the amount 
of fat equivalent in the duodenum to stimulate gallbladder 
emptying offered better predictive performances.23 Thus, 
(6)
MTTA,L=TVMTTA,L ⋅ (1−0.279 ⋅FEM)
⋅(1+0.00614 ⋅ (gcarb−93)) ⋅exp(ηi3)
Figure 4 Visual predictive checks of the gallbladder volume (top) and total bile acids plasma concentration (bottom) time- courses for 
each of the four test drinks. The vertical lines represent the time of the test drink intake. OGTT, oral glucose tolerance test. Shaded 
areas represent the 95% confidence interval around the specified percentiles, based on 1,000 simulations.
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a GE model was integrated to predict efatduod kinetics for 
the different test drinks. Our results are in line with previ-
ous findings, carbohydrates had a relatively low potency 
(Pcarb = 5.7%) to trigger gallbladder emptying as compared 
to fats (Pfat = 100%), unlike proteins (Pprot = 82%).
4,31
The T2D status was associated with a shortened HLRB 
and a decreased RGB,out resulting in higher fasting (base-
line) and postprandial (peak) TBA plasma concentrations in 
comparison to healthy volunteers. Consistent with our find-
ings, alterations of the bile acid homeostasis (e.g., elevated 
plasma concentrations) have previously been described 
in subjects with T2D, and are likely due to their close rela-
tionship with the glucose and energy metabolism.19,32 The 
RGB,out was also found to be inversely correlated with age, 
and is likely the result of a decreased gallbladder respon-
siveness with age.33 However, unlike our previous findings, a 
linear relationship between efatduod and RGB,out was selected 
over a Michaelis- Menten, our previous gallbladder emptying 
model did not, however, account for the EHC of bile acids.23
Angelin et al.8 suggested that the multiple postprandial 
peaks in TBA plasma concentrations are likely result of the 
recirculation of reabsorbed bile acids. Nevertheless, only as-
suming a constant gallbladder emptying did not allow the 
model to predict the secondary peaks and, thus, the hypoth-
esis of postprandial gallbladder refilling periods was made. 
Despite the absence of gallbladder volume data beyond 
60 minutes, signs of postprandial refilling could be seen in 
the data for all test drinks (Figure 1, top panels). This the-
ory is also supported by the work from Howard et al.34 and 
Jazrawi et al.35 who showed that postprandial gallbladder 
motility is characterized by sequences of emptying and re-
filling phases of different intensities.
Throughout model development, the use of the TBA data 
was preferred over the use of the individual bile acids data 
for being relatively constant (Figure 2). Indeed, focusing the 
modeling on TBA circumvented the need for implementa-
tion of conjugation and deconjugation processes into the 
model.1,2 The proposed model is thought to be adaptable to 
the prediction of specific bile acids’ kinetics.
The determination of the structure and parameters of TBA 
distribution was not possible solely based on their endog-
enous plasma concentrations. A two- compartment model 
linked to a liver compartment (clearance site) was devel-
oped based on radiolabeled total CA data.25 The estimated 
volume and clearance values were in line with the reported 
rapid and contained distribution of TBA.2,9 The total CA 
serum concentrations were used as surrogate of TBA distri-
bution. This assumption is supported by results from Cowen 
et al.9 showing that principal bile acids had similar protein 
binding and disappearance rates. Additionally, the sensitiv-
ity analysis revealed the model was not sensitive to the TBA 
distribution parameters.
The general structure of the EHC TBA model was based 
on the different anatomical sections of the EHC, an approach 
comparable to the model developed by Hofmann et al.36 
(Figure 3). However, unlike the bottom- up approach used 
by Hofmann et al.36, our model development was mostly 
data driven (top- down approach) leading to a few noticeable 
Figure 5 Model- based simulations of gallbladder volume (top) and total bile acids plasma concentration (bottom) time- course for 
each of the four test drinks. For each panel, different prediction intervals (shaded areas) and the median (solid lines) were calculated 
based on 1,000 model simulations for a typical individual (i.e., non- diabetic, sex: male, weight: 70 kg, height; 1.7 m, and age: 64 years 
old). The vertical lines represent the time of the test drink intake. OGTT, oral glucose tolerance test.
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differences. Transit compartments were used to account for 
the delay of bile acids transiting through the small intestine. 
The MTTA,L, the mean transit time of bile acids to the lower 
small intestine, was found to be influenced by gender and 
the amount of ingested carbohydrates. An effect of gender 
on the response of bile acids to nutritional intake was also 
reported by Fiamoncini et al.37 The effect of carbohydrates 
has, to our knowledge, not been reported, but might be 
linked to an effect of gut hormones, such as the glucagon- 
like peptides.38 Meal- specific effects could also be seen with 
the OGTT 75 g for which FAU, the fraction of TBA absorbed 
in the upper small intestine, was increased from 21.6% to 
48.6%. Although the reason behind this effect remains un-
clear it could be linked to the properties of the test drink, 
such as pH acting on the ionization of the bile acids in the 
small intestine.1,2 The decreased hepatic extraction with the 
high- fat test drink was unexpected and differs from finding 
by Angelin et al.8, who reported constant hepatic extraction 
before and after meal intake in cholecystectomized patients. 
A possible explanation for this effect may lay in the interac-
tion of bile acids with the lipoproteins, which are absorbed 
via the lymphatic system, thus, possibly allowing them to 
evade the first- pass metabolism.12,39
The total parameter variability (BSV and BOV) was dom-
inated by BOV for all parameters except EH and the base-
line gallbladder volume (Table S2). The large BOV indicates 
that variability is not primarily explained by genetic factors, 
as described by Fiamoncini et al.37 Nonetheless, restricting 
the parameter space by accounting for individual parameter 
correlations (Table S3) significantly improved the predictive 
performance of the model (Figure 4).
This study presents several limitations. First, the pre-
dictions of the kinetics of TBA in the lower small intestine, 
upper small intestine, and liver compartments remain to 
be evaluated based on appropriate data. Second, the gall-
bladder data were evaluated by ultrasonography only and 
no later than 60 minutes following the intake of test drinks. 
Measurements beyond 60 minutes would have helped 
to confirm our hypothesis regarding gallbladder refilling. 
Furthermore, as described by Jazrawi et al.,35 the combined 
use of scintigraphy and ultrasonography measurements 
would have provided more information on the emptying and 
refilling patterns of the gallbladder. Third, in vivo the hepatic 
clearance QH is varying continuously between fasting and 
postprandial states.40 However, such dynamic changes 
could not be identified solely based on the current data and 
QH was, hence, fixed to literature values.
28 Fourth, TBA dis-
tribution parameters were obtained using data from radio-
labeled total CA, and fifth the TBA pool was assumed to 
be constant throughout time. Finally, the models were de-
veloped based on test drinks (i.e., liquid meals), data and 
extrapolation to solid meals has yet to be tested as it could 
influence GE rate and the EHC of bile acids. Despite these 
limitations we consider the established model an important 
step toward better predictions of functional bile concentra-
tions in response to caloric intake.
In conclusion, an NLME approach was used to develop 
an EHC modeling framework describing the postprandial re-
lationship among the GE, the gallbladder emptying–refilling 
patterns, and the spillover of TBA in plasma. The presented 
modeling framework could support drug development by 
improving the prediction food effect on rate and extent of 
drug absorption or drug- drug interactions related to the 
EHC of bile acids. These applications could be facilitated 
by the integration of this model into larger systems pharma-
cology models. Finally, the model could aid in the research 
on the onset and evolution of bile acid- related pathologies.
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